HeartBEATS from Lifelong Learning‪™‬ American Heart Association

Conversation around how a cardiologist or non-endocrinologist starts GLP-1 RAs. We will explore dose escalation, concerns about hypoglycemia, managing other glucose lowering agents, how to deal with adverse effects and other important topics.
Claim CE Credit at https://bit.ly/3xqdZJg 

Conversation around the barriers to GLP-1 RAS. Dr. Trudy Gaillard and Dr. Monica Peek discuss adverse effects, cost, strategies when taking with other medications, social determinants of health, and educational support.
Claim CE and MOC Credit at https://bit.ly/4bmIxu0

Conversation around patient selection and GLP-1 RAs. The speakers will explore the effects of GLP-1 RAs and SGLT-2 inhibitors on clinical outcomes and CVD risk factors. 

Claim CE Credit at https://bit.ly/4aSgdzz
 

It has been essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness.  Dr. Jeff Hsu talks with Dr. Carrie Harvey about the cardiovascular risks with COVID-19, diagnostic tools, clinical manifestations, short and long-term cardiovascular outcomes after recovery from the acute infection. Recommendations for cardiac wellness will also be discussed. Claim CE and MOC Credit at https://bit.ly/3QISie3

In this episode, a panel of experts discuss existing VTE treatment options, algorithms, corresponding safety and efficacy profiles along with safety and efficacy data, and protocols to address treatment pathways.
Claim CE and MOC Credit at https://bit.ly/VTEIII

COVID-19 care is now mostly provided outside of hospital settings. Early diagnosis and therapeutic intervention for those who are at increased risk of progression to severe COVID-19 may improve outcomes. Dr. Jeff Hsu talks with Dr. Mary Brennan about the symptoms associated with the different stages of SARS-CoV-2 and choosing the appropriate outpatient therapeutic treatment.
 
CE and ABIM MOC credits available: https://bit.ly/3PeZRIy